Immuneering Corporation (IMRX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
3. 59
-0.05
-1.3736%
$
143.03M Market Cap
- P/E Ratio
- Div Yield
747,787 Volume
-1.89 Eps
$ 3.64
Previous Close 
Want to track IMRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Immuneering Corporation (IMRX) Statistics
Valuation metrics
Market Cap 143.03M
Enterprise value 105.34M
Trailing P/E (ttm) -3.79
Forward P/E -
PEG ratio -0.06
Price/Sales (ttm) -
Price/Book (mrq) 1.34
Enterprise Value/Revenue -
Enterprise Value/EBITDA -1.7
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 709.7K
Average volume (90 days) 688.59K
Price summary
52-Week low 3.38
52-Week high 8.48
Beta -
50-Day moving average 4.34
200-Day moving average 5
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.28%
Return on equity -0.27%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.89
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 2.32
Total debt (mrq) -
Total Debt/Equity (mrq) 0.02
Current ratio (mrq) 19.47%
Book value per share (mrq) 2.95
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
